Hi,
distro packages have nothing todo with this hack.
Kannel has following rule:
no specific workarounds (and this hack is only India specific and is
only for commercial MT)
If we break this rule we have to do more work to allow all the needed
workarounds and maintain these,
what is the real work.
The second think about this patch: why should this go into SMPP
module? why it's not possible to do
at application level before submitting message to kannel? I really
don't see reason to accept this patch.
Thanks,
Alex
Am 26.02.2009 um 08:09 schrieb Enver ALTIN:
Hi Stipe,
At first glance, my reaction was neutral like you but then I think
somehow it needs to go in.
A comfortable Kannel experience today is to download the source code
from CVS, build and use that. This was how a Slackware or Gentoo user
would get things done nearly a decade ago, but things change.
There are excellent distributions like Debian, Ubuntu, Fedora and
SuSE;
and that's what people actually use. If there is a Kannel package
provided by their distribution of choice, they use that.
Now, think about people from India. You're really putting a
roadblock on
their way. They just can't use the OpenSolaris package as it is, if
there's one, they'll have to rebuild it. And it's really dumb to have
development tools installed on a production server, for many reasons.
Short story, it should be in.
PS: We really should start encouraging people to use distro packages
at
some point.
On Wed, 2009-02-25 at 16:34 +0100, Stipe Tolj wrote:
Hi list,
according to the TRAI, all SMSC in India need to use prefixes in
TON=5
(alphanumeric) source addresses since 2009-02-01.
Please find a corresponding patch against 1.4.3 and CVS HEAD at
http://www.kannel.org/~tolj/patchsets/TRAI/
along with the official direction statement of the TRAI.
I'm not sure if we want to "mainline" this into CVS, since it
exposes another
config directive to the smsc group. But as this is of general
interest to all
users from India, please feel free to incorporate the patch to your
production
systems.
Any opinions if we want this (or modified) to go into CVS? I'm +0
on it, not
really sure and want to hear some opinions from the group.
Stipe
--
Enver
